Duchenne Muscular Dystrophy clinical trials at UCSF
2 in progress, 1 open to eligible people
open to eligible males ages 5 years and up
This study is a long-term study of ataluren in participants with nonsense mutation Duchenne muscular dystrophy.
Oakland, California and other locations
Sorry, in progress, not accepting new patients
This is a Phase 2, open-label, single arm trial of pamrevlumab (FG-3019) to estimate pamrevlumab's safety and efficacy in non-ambulatory subjects with DMD.
San Francisco, California and other locations